ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

0ELV Guerbet Sa

27.775
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Guerbet Sa LSE:0ELV London Ordinary Share FR0000032526 GUERBET ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 27.775 27.10 28.45 5 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Medicinal Chems,botanicl Pds 799.96M 23.87M 1.8880 20.13 480.36M

Guerbet: Financial agenda for 2024

15/01/2024 5:00pm

GlobeNewswire Inc.


Guerbet (LSE:0ELV)
Historical Stock Chart


From Nov 2023 to May 2024

Click Here for more Guerbet Charts.
Guerbet: Financial agenda for 2024

Financial agenda for 2024

Villepinte, 15 January 2024: Guerbet (FR0000032526), a global specialist in contrast agents and solutions for medical imaging, is announcing its financial agenda for 2024.

Publications calendar
  • 2023 ANNUAL REVENUE
February 08, 2024, after trading
  • 2023 ANNUAL RESULTS
March 20, 2024, after trading
  • 2024 1ST QUARTER REVENUE
April 25, 2024, after trading
  • ANNUAL SHAREHOLDERS’ MEETING
May 24, 2024
  • 2024 2ND QUARTER REVENUE
July 25, 2024, after trading
  • 2024 FIRST HALF RESULTS
September 25, 2024, after trading
  • 2024 3RD QUARTER REVENUE
October 24, 2024, after trading

 

 

About Guerbet

At Guerbet, we build lasting relationships so that we enable people to live better. That is our purpose. We are a leader in medical imaging worldwide, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging. A pioneer in contrast media for 95 years, with more than 2,600 employees worldwide, we continuously innovate and devote 10% of our sales to research and development in four centres in France, Israel, and the United States. Guerbet (GBT) is listed on Euronext Paris (segment B – mid caps) and generated €753 million in revenue in 2022.

Contacts :

Guerbet      Jérôme Estampes, Chief Financial Officer + 33.1.45.91.50.00 / jerome.estampes@guerbet.comClaire Lauvernier, Group Communication Director +33.6.79.52.11.88 / claire.lauvernier@guerbet.com

Actifin         Marianne Py, Financial Communication + 33.1.80.48.25.31 / marianne.py@seitosei-actifin.com Jennifer Jullia, Media Relations +33.1.56.88.11.19 / jennifer.jullia@seitosei-actifin.com

Attachment

  • Guerbet_PR Agenda 2024

1 Year Guerbet Chart

1 Year Guerbet Chart

1 Month Guerbet Chart

1 Month Guerbet Chart